Alopexx Vaccine LLC announced that it has completed a Phase 1 clinical trial with AV0328, a vaccine targeting the broadly...
Read moreRoche announced that new OCREVUS® data are being presented at the 7th Joint European Committee for Treatment and Research in...
Read more
BrainStorm Cell Therapeutics Inc announced that the first patients have been enrolled in the Phase 3 clinical trial of NurOwn®...
Read more
Seattle Genetics, Inc. and Astellas Pharma Inc. announced dosing of the first patient in EV-201, a registrational phase 2 clinical...
Read more
Exelixis, Inc. announced that its partner Daiichi Sankyo Company, Limited (“Daiichi Sankyo”) has reported positive top-line results from a phase...
Read more
Novartis announced, first of its kind phase III data showing Cosentyx (secukinumab) delivered high and long-lasting skin clearance in patients...
Read more
Aurigene Discovery Technologies Ltd, a wholly owned subsidiary of Dr. Reddy’s Laboratories Ltd and Curis, Inc. have announced plans to...
Read more
GlaxoSmithKline plc, announced the publication of full results from the phase III studies for mepolizumab in chronic obstructive pulmonary disease...
Read more
ESSA Pharma Inc. , a clinical-stage pharmaceutical company focused on the development of novel small molecule drugs for the treatment of...
Read more
Antibe Therapeutics has announced that it has received approval from Health Canada to initiate a Phase 2, double-blind, gastrointestinal endoscopy...
Read more
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
